Search

Displaying all 2 results
DrugBest match

Teplizumab

go.drugbank.com/drugs/DB06606
ApprovedInvestigational

Teplizumab (teplizumab-mzwv) is a humanized IgG1 kappa CD3-directed monoclonal antibody used to delay the onset of type 1 diabetes (T1D). T1D is an autoimmune condition in which T cell-mediated destruction of pancreatic β cells leads to loss of insulin production, impaired glycemic control, and reliance on exogenous...

  1. Indication

    Stage 3 Type 1 Diabetes Mellitus

    go.drugbank.com/conditions/DBCOND0153000
    Drugs: Teplizumab